Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Gut|September 9, 2021
Patients with mesenchymal tumours and high <i>Fusobacteriales</i> prevalence have worse prognosis in colorectal cancer (CRC)Manuela Salvucci, Nyree Crawford, Katie Stott, et al.
Archives of Oral Biology|August 15, 2025
Role of Fusobacterium nucleatum in the pathogenesis of oral squamous cell carcinoma: A systematic review of molecular mechanisms and signalling pathwaysBara'a El-Dwaikat, Ikhlas El Karim, Daniel B Longley, et al.
Communications Chemistry|January 29, 2025
Chemical- and photo-activation of protein-protein thiol-ene coupling for protein profilingAndré Campaniҫo, Marcin Baran, Andrew G Bowie, et al.
Molecular Cancer Therapeutics|December 24, 2005
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIPLeeona Galligan, Daniel B Longley, Miranda McEwan, et al.
Seminars in Oncology|June 13, 2003
The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cellsDaniel B Longley, Tariq Latif, John Boyer, et al.
Plos Computational Biology|September 26, 2019
Heterogeneous responses to low level death receptor activation are explained by random molecular assembly of the Caspase-8 activation platformAnna Matveeva, Michael Fichtner, Katherine McAllister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2010
Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancerJoan N Kyula, Sandra Van Schaeybroeck, Joanne Doherty, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 5, 2010
In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotideAndrew E Logan, Timothy R Wilson, Catherine Fenning, et al.
Plos One|May 17, 2012
Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerCatherine Wilson, Pamela J Maxwell, Daniel B Longley, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 26, 2010
Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosisNyree Crawford, Alex D Chacko, Kienan I Savage, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Gut|September 9, 2021
Patients with mesenchymal tumours and high <i>Fusobacteriales</i> prevalence have worse prognosis in colorectal cancer (CRC)Manuela Salvucci, Nyree Crawford, Katie Stott, et al.
Archives of Oral Biology|August 15, 2025
Role of Fusobacterium nucleatum in the pathogenesis of oral squamous cell carcinoma: A systematic review of molecular mechanisms and signalling pathwaysBara'a El-Dwaikat, Ikhlas El Karim, Daniel B Longley, et al.
Communications Chemistry|January 29, 2025
Chemical- and photo-activation of protein-protein thiol-ene coupling for protein profilingAndré Campaniҫo, Marcin Baran, Andrew G Bowie, et al.
Molecular Cancer Therapeutics|December 24, 2005
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIPLeeona Galligan, Daniel B Longley, Miranda McEwan, et al.
Seminars in Oncology|June 13, 2003
The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cellsDaniel B Longley, Tariq Latif, John Boyer, et al.
Plos Computational Biology|September 26, 2019
Heterogeneous responses to low level death receptor activation are explained by random molecular assembly of the Caspase-8 activation platformAnna Matveeva, Michael Fichtner, Katherine McAllister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2010
Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancerJoan N Kyula, Sandra Van Schaeybroeck, Joanne Doherty, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 5, 2010
In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotideAndrew E Logan, Timothy R Wilson, Catherine Fenning, et al.
Plos One|May 17, 2012
Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerCatherine Wilson, Pamela J Maxwell, Daniel B Longley, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 26, 2010
Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosisNyree Crawford, Alex D Chacko, Kienan I Savage, et al.
Pageof 12